News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes Michael O'Riordan December 08, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow Michael O'Riordan November 02, 2023
News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity Todd Neale August 08, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit Michael O'Riordan June 30, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Daily News US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy Michael O'Riordan June 19, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Conference News ACC 2023 CRP More Predictive of Future Events Than LDL in Statin-Treated Patients Caitlin E. Cox March 14, 2023
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023
News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022